GT-0001X

N/A

Report date: 2024/11/12 15:24:03

Base Information

Drug NameGT-0001X
Drug Alias NameGT0001X
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceAdenosine Deaminase RNA Specific B1 inhibitors
TargetsAdenosine Deaminase RNA Specific B1
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGene Therapy Research Institution Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGene Therapy Research Institution Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A